Posted by Squiggles on March 1, 2007, at 7:36:26
In reply to Re: Drug manufacturing and quality control » Squiggles, posted by laima on February 28, 2007, at 21:14:00
>
> It may not be an official rule, but I actually think it's a spankable offense to insist someone's condition, diagnosis, or experience is imaginary. Very hurtful, too. If this isn't what you are inferring, what are you trying to tell me?
>
>Thank you for your courteous reply. OK- I am suggesting that it would be very difficult to detect lack of bioavailability or bioequivalence in generics once they are on the market. If I understand bioavailability correctly, it may be easier to detect that. So, my point is that you would have to do a really massive statistical test on *suspected* bad generics. You may as well try it on brand-name ones. The FDA, and Health Canada sometimes *do* find error in these drugs and report it, but I don't know that there are more such reports for brand-name drugs than generics-- I don't think so.
Squiggles
poster:Squiggles
thread:735309
URL: http://www.dr-bob.org/babble/20070224/msgs/737278.html